Investigation of Sevoflurane-Induced Apoptotic Damage in Human Cardiomyocytes and the Protective Efficacy of Ascorbic Acid
Medicina · 12.05.2026 · 62 (5) · 945
DOI: 10.3390/medicina62050945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, online erschienen am 12.05.2026. Verfasst von Eyüp Aydoğan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Reanimation, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07425 Alanya, Türkiye. Hauptthemen laut MEDLINE: Sevoflurane, Ascorbic Acid, Myocytes, Cardiac, Apoptosis. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Sevoflurane, a widely used volatile anesthetic, can induce oxidative stress and apoptosis, but the underlying mechanisms in human cardiomyocytes remain unclear. This study investigated the role of transient receptor potential vanilloid 1 (TRPV1) channels in sevoflurane-induced cardiotoxicity and the potential mitigating effect of ascorbic acid. Materials and Methods: Human cardiomyocytes were exposed to sevoflurane (5.1%, 6 h) and/or ascorbic acid (1 mM, 30 min), with or without the TRPV1 channel antagonist capsazepine and with the TRPV1 channel agonist Capsaicin. Intracellular calcium, reactive oxygen species (ROS), apoptosis, mitochondrial membrane potential, and caspase-3/9 activities were assessed.
Results
Sevoflurane significantly increased intracellular calcium levels, ROS production, mitochondrial depolarization, apoptosis, and caspase-3/9 activity compared with controls (p < 0.001). These effects were attenuated by capsazepine, suggesting a role for TRPV1 involvement. Ascorbic acid pretreatment significantly reduced sevoflurane-induced elevations in all parameters (p < 0.001). Combined ascorbic acid and capsazepine treatment yielded further reductions in calcium, ROS, apoptosis, and caspase activities compared to ascorbic acid alone (p < 0.05).
Conclusions
Sevoflurane induces apoptosis in human cardiomyocytes via ROS-mediated activation of the TRPV1 channel, leading to calcium overload, mitochondrial dysfunction, and caspase-dependent cell death. Ascorbic acid exerts mitigating effects by reducing oxidative stress and modulating TRPV1 channel activity, suggesting a potential therapeutic strategy for myocardial protection during sevoflurane anesthesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Reanimation, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07425 Alanya, Türkiye.
- Department of Physiology, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07425 Alanya, Türkiye.
- Department of Cardiovascular Surgery, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07425 Alanya, Türkiye.
Zitieren
APA
Aydoğan, E., Övey, İ. S., & Karahan, O. (2026). Investigation of Sevoflurane-Induced Apoptotic Damage in Human Cardiomyocytes and the Protective Efficacy of Ascorbic Acid. Medicina, 62(5), 945. https://doi.org/10.3390/medicina62050945
Vancouver
Aydoğan E, Övey İS, Karahan O. Investigation of Sevoflurane-Induced Apoptotic Damage in Human Cardiomyocytes and the Protective Efficacy of Ascorbic Acid. Medicina. 2026;62(5):945. doi:10.3390/medicina62050945
BibTeX
@article{Aydoan2026,
author = {Aydoğan, Eyüp and Övey, İshak Suat and Karahan, Oğuz},
title = {Investigation of Sevoflurane-Induced Apoptotic Damage in Human Cardiomyocytes and the Protective Efficacy of Ascorbic Acid},
journal = {Medicina},
year = {2026},
volume = {62},
number = {5},
pages = {945},
doi = {10.3390/medicina62050945}
}
EUVIMED